Brief: Alzchem Group Appoints Dr. Jürgen Sans As Chief Operating Officer With Effect From 1 January 2026
23/05/2025 08:03
May 23 (Reuters) - ALZCHEM GROUP AG ACT1.DE: SUCCESSFULLY COMPLETES LONG-TERM SUCCESSION PLANNING FOR ITS MANAGEMENT BOARD: SUPERVISORY BOARD APPOINTS DR. JÜRGEN SANS AS CHIEF OPERATING OFFICER WITH EFFECT FROM 1 JANUARY 2026 Source text: ID:nEQ22l5qza Further company coverage: ACT1.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AlzChem AG
See all newsGermany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Brief: Alzchem Confirms Full-year 2026 Outlook
Brief: Alzchem Selects Bushy Park, South Carolina For Nitroguanidine Production Facility
Germany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group